Inverness Medical Innovations Australia Pty Ltd T/A Alere

데이터베이스에서 발견된 의료기기 1건 데이터베이스에서 발견된 의료기기 22 건

  • 모델명 / 제조번호(시리얼번호)
    Alere Cholestech LDX ALT-AST Cassette (An in vitro medical device (IVD) used for the quantitative determination of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in whole blood)Catalogue Number: CT12-788Lot Number: 297313AARTG Number: 160951
  • 모델명 / 제조번호(시리얼번호)
    Alere Cholestech LDX hsCRP Cassette (An in vitro medical device (IVD) used in the quantitative determination of C-reactive protein in whole blood or serum )Catalogue Number: CT12-807Lot Numbers: 274632 & 281847/14ARTG Number: 160951
  • 모델명 / 제조번호(시리얼번호)
    Alere Cholestech LDX Multianalyte Control (An in vitro diagnostic medical device used to monitor the performance of total cholesterol (TC), high density lipoprotein (HDL), triglycerides (TRG), glucose (GLU), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) test procedures on the Alere Cholestech LDX System)Catalogue Number: CT88769Lot Numbers: C2572, C2572A, C2593 & C2593AARTG Number: 160951
  • 모델명 / 제조번호(시리얼번호)
    epoc BGEM Test Card (blood gas, electrolyte and metabolite test card panel), An in vitro diagnostic medical device (IVD).Catalogue Number: CT-1004-00-00Lot Numbers: 07-12289-00 & 07-01263-00ARTG Number: 198588
  • 모델명 / 제조번호(시리얼번호)
    Panbio Dengue IgM Capture ELISA, An in vitro diagnostic medical device (IVD)Catalogue numbers: E-DEN01M / E-DEN01M05Lots: 12306, 12348 & 13007ARTG Number: 22341
하나 더 17 건 더

유사한 이름을 가진 의료기기 1건 유사한 이름을 가진 의료기기 1 건

데이터에 대해 더 자세히 알아보기 여기

  • 제조사 모회사 (2017)
  • 제조사 의견
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NZMMDSA